Furthermore, in vivo application of (S)-(-)-blebbistatin O-benzoate significantly suppressed dermatitis symptoms, reduced serum IgE levels, and decreased the number of mast cells infiltrating the skin tissue. This evidence concerns the gene IGHE and dermatitis.